tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (SNPHY)
OTHER OTC:SNPHY

Compare Santen Pharmaceutical Co (SNPHY) vs. Competitors

Compare
6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Santen Pharmaceutical Co
$11.00
$3.53B
17.72
10.46%
AstraZeneca
$93.99
$297.65B
31.74
43.10%
5 Buy
0 Hold
0 Sell
Strong Buy
Bristol-Myers Squibb
$56.62
$116.08B
19.25
1.27%
8 Buy
11 Hold
1 Sell
Moderate Buy
GlaxoSmithKline
$49.12
$101.52B
14.29
49.76%
1 Buy
2 Hold
3 Sell
Moderate Sell
Grifols SA
$8.78
$8.12B
15.05
19.54%
Sanofi
$47.47
$116.05B
11.91
-3.85%
2 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SNPHY
Santen Pharmaceutical Co
11.00
1.16
11.81%
AZN
AstraZeneca
93.99
28.75
44.08%
BMY
Bristol-Myers Squibb
56.62
3.04
5.67%
GSK
GlaxoSmithKline
49.12
17.06
53.19%
GRFS
Grifols SA
8.93
1.76
24.55%
SNY
Sanofi
47.47
-1.70
-3.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts